Key facts
- This page summarizes Tony W. Ho's Form 4 filing for iTeos Therapeutics, Inc. (ITOS).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 13 Jun 2024, 20:00.
Tony W. Ho - 11 Jun 2024 Form 4 Insider Report for iTeos Therapeutics, Inc. (ITOS)
- Reporting relationship
- Director
- Issuer ticker
- ITOS
- Reported as of
- 11 Jun 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 13 Jun 2024, 20:00:13 UTC
- Prior SEC filing
- 15 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Adi Osovsky, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Tony W. Ho filed Form 4 for iTeos Therapeutics, Inc. (ITOS) on 13 Jun 2024.
Change
- Previous filing in this sequence was filed on 15 Jun 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ITOS
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +24,200
- Change %
- Price
- $0.000000
- Shares after
- 24,200
- Date
- 11 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 24,200
- Exercise price
- $16.32
* marks a reported price that did not pass the local price check.